Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Other Accumulated Expenses (2016 - 2025)

Aethlon Medical filings provide 15 years of Other Accumulated Expenses readings, the most recent being $472164.0 for Q1 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 119.57% to $472164.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $472164.0, a 119.57% increase, with the full-year FY2025 number at $472164.0, up 119.57% from a year prior.
  • Other Accumulated Expenses hit $472164.0 in Q1 2025 for Aethlon Medical, up from $32203.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q4 2022 to a low of $32203.0 in Q2 2024.
  • Median Other Accumulated Expenses over the past 5 years was $496074.0 (2023), compared with a mean of $538243.1.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 179.72% in 2022 and later crashed 93.7% in 2024.
  • Aethlon Medical's Other Accumulated Expenses stood at $421956.0 in 2021, then skyrocketed by 179.72% to $1.2 million in 2022, then crashed by 60.49% to $466329.0 in 2023, then plummeted by 93.09% to $32203.0 in 2024, then surged by 1366.21% to $472164.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $472164.0 (Q1 2025), $32203.0 (Q2 2024), and $215038.0 (Q1 2024) per Business Quant data.